Monitor the JAGX share price closely from April 30 to May 15 to see if it can sustain above $1.00 for 10 consecutive days. The reverse split is a temporary fix; the underlying issue of low investor confidence remains, and failure to meet the deadline will trigger delisting, severely impacting liquidity and share value.
Price Chart
Executive Summary
Jaguar Health received a conditional extension from Nasdaq to maintain its listing by demonstrating a $1.00 bid price for 10 consecutive days by May 15, 2026. To meet this requirement, the company announced a 1-for-35 reverse stock split effective April 30, 2026. Failure to comply will result in delisting.
Key Facts
- Nasdaq granted a conditional extension until May 15, 2026, for Jaguar Health to regain compliance with the $1.00 minimum bid price rule.
- The company must maintain a closing bid price of at least $1.00 for 10 consecutive business days by the deadline.
- A 1-for-35 reverse stock split was approved and becomes effective April 30, 2026, to artificially boost the share price.
- Nasdaq explicitly stated the company is not eligible for a standard 180-day compliance period due to a prior reverse split within the last two years.
- The Nasdaq Hearings Panel retains jurisdiction until September 1, 2026, and any further non-compliance will result in immediate delisting.
Financial Impact
The reverse stock split will reduce the number of outstanding shares by a factor of 35, increasing the per-share price proportionally. This is a structural change with no impact on the company's $5M market cap.
Risk Factors
- Failure to maintain a $1.00 bid price for 10 consecutive days by May 15, 2026, will result in Nasdaq delisting.
- The reverse stock split may be perceived negatively by the market as a sign of financial distress, potentially leading to further selling pressure.
- Even if the bid price requirement is met, the company remains under heightened scrutiny from Nasdaq until September 1, 2026, with no tolerance for any further listing violations.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-179391 |
| Document: d109088dex991.htm | 0001193125-26-179391 |
| Document: d109088dex31.htm | 0001193125-26-179391 |
| Document: 0001193125-26-179391-index-headers.html | 0001193125-26-179391 |
| Document: 0001193125-26-179391-index.html | 0001193125-26-179391 |
| Document: 0001193125-26-179391.txt | 0001193125-26-179391 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | S-3 | $2.04 | awaiting T+60 | — | $2.22 (−9.07%) |
Oct 8, 2026 18d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.22 (+53.55%) |
Oct 5, 2026 22d ago | 8-K | $4.73 | awaiting T+60 | — | $2.22 (+52.96%) |
Sep 28, 2026 29d ago | 8-K | $6.02 | awaiting T+60 | — | $2.22 (+63.04%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.22 (+71.10%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.22 (+68.48%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.22 (+68.48%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.22 (−93.54%) |
Sep 15, 2026 5w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.22 (−890.65%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.22 (+78.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers